been grown, yield actually declined (y ¼ 21227.7x + 3e06) but yields were increasing in Western Europe (y ¼ 2521x 2 5e6). In other words, if we were to concentrate only on the period when the US was growing essentially all its GM maize, we would find that the yields were decreasing or static, while Western Europe's yields increased significantly over this same period. Hence our argument that GM did not contribute significantly to yield increases in the US holds.
Further, the fragility of the small data set, the one suggested by Apiolaza corresponding to the GM maize growing period in the US, is shown by how much the slope of the regression line changes by the addition of even a single year. Consider the US yield data over a series differing by one year during the period when the US produced 90% of all the GM maize harvested to date (beginning in 2001). The regression from 2001 to 2010 was y ¼ 1560x 2 3e06 and the slope decreased 28% when the data set was extended to include 2011. The regression from 2001 to 2011 was y ¼ 1119.8x 2 2e06 and the slope decreased another 78% when the data set was extended further to include 2012 (y ¼ 248.8x 2 407,204).
In contrast, the addition of single-year increments out to 2012 has little effect on our original 50-year data set (Figure 2 has further diverged from the US regression line with the addition of 2011 and 2012 yield data, as we predicted (Heinemann et al. 2014) . The direction of the yield changes is consistent with our observation that there has been no obvious comparative yield benefit from the adoption of GM crops in the US compared to the biotechnologies in use in Western Europe.
Apiolaza then suggests incorrectly that we have assumed that North America and Western Europe have 'the same intrinsic yield'. He argues that the US has lower maximum intrinsic yields than Western Europe, and this difference explains the lower yield gains relative to Western Europe. We presented the alternative possibility that the US agroecosystem is operating further below its maximum attainable yields than is Western Europe, which is supported by research showing that Western Europe is performing more closely to its maximum yield than is the US (Licker et al. 2010) . We argue that the US still has the possibility to increase annual yields. It has, however, not made the choices that result in it achieving its full yield potential. This argument is further strengthened by the fact that Western Europe has higher yield gains in wheat and oilseed rape, not just higher yields than the US and Canada, respectively.
The second issue is that Apiolaza speculates that lower yields in the US are due to land being cheaper than additional inputs, for example, of pesticide and fertilizer, and the opposite is true for Western Europe. That argument is interesting. However, we are unaware of comprehensive evidence demonstrating that the Western European farmers are using more expensive inputs than US farmers. According to the latest FAOSTAT data, for example, Western Europe uses more nitrogen than the US, but it is decreasing its use while the US is not. Western Europe now uses less phosphorus per area than the US and is decreasing its use while the US is not. The trends are similar for pesticides (Heinemann et al. 2014) . In any case, if expansion onto cheap but marginal land explains the US's relative inefficiency, this only supports our conclusion that the larger policy context of the agroecosystem must be considered when choosing a biotechnology pathway. As land becomes limiting for agriculture, inefficient practices will not be economically sustainable. The US will still need biotechnology options that improve yield on all agricultural lands. In this way, Western Europe has perhaps provided some insights into how the US might transition to a higher yield agroecosystem.
Finally, we agree with Apiolaza that a careful analysis of pesticide use and its impact on yield would be useful, if comprehensive data on pesticide use by type, crop acreage, and country were available.
The conclusion we drew in our paper (Heinemann et al. 2014) was that GM crops of the kind in use are not the problem: they are a symptom of a long-term policy in North America that is not as effective as possible at advancing a biotechnology package that both increases yield and reduces pesticide use -characteristics of a future agriculture that we all want.
